These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 25305716)

  • 1. Novel amino-β-lactam derivatives as potent cholesterol absorption inhibitors.
    Dražić T; Molčanov K; Sachdev V; Malnar M; Hećimović S; Patankar JV; Obrowsky S; Levak-Frank S; Habuš I; Kratky D
    Eur J Med Chem; 2014 Nov; 87():722-34. PubMed ID: 25305716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and evaluation of novel amide amino-β-lactam derivatives as cholesterol absorption inhibitors.
    Dražić T; Sachdev V; Leopold C; Patankar JV; Malnar M; Hećimović S; Levak-Frank S; Habuš I; Kratky D
    Bioorg Med Chem; 2015 May; 23(10):2353-9. PubMed ID: 25882530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and in vitro evaluation of inhibitors of intestinal cholesterol absorption.
    Kvaernø L; Werder M; Hauser H; Carreira EM
    J Med Chem; 2005 Sep; 48(19):6035-53. PubMed ID: 16162006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterocyclic ring scaffolds as small-molecule cholesterol absorption inhibitors.
    Ritter T; Kvaernø L; Werder M; Hauser H; Carreira EM
    Org Biomol Chem; 2005 Oct; 3(19):3514-23. PubMed ID: 16172689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of 3-(aryl)alkenyl-beta-lactams by an efficient application of olefin cross-metathesis on solid support.
    Testero SA; Mata EG
    Org Lett; 2006 Oct; 8(21):4783-6. PubMed ID: 17020302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-lactam cholesterol absorption inhibitors.
    Burnett DA
    Curr Med Chem; 2004 Jul; 11(14):1873-87. PubMed ID: 15279572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Diversity by Olefin Cross-Metathesis on Solid Support. Generation of Libraries of Biologically Promising β-Lactam Derivatives.
    Méndez L; Poeylaut-Palena AA; Mata EG
    Molecules; 2018 May; 23(5):. PubMed ID: 29772720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, docking and evaluation of in vitro anti-inflammatory activity of novel morpholine capped β-lactam derivatives.
    Heiran R; Sepehri S; Jarrahpour A; Digiorgio C; Douafer H; Brunel JM; Gholami A; Riazimontazer E; Turos E
    Bioorg Chem; 2020 Sep; 102():104091. PubMed ID: 32717692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Madin-Darby canine kidney II cells: a pharmacologically validated system for NPC1L1-mediated cholesterol uptake.
    Weinglass AB; Köhler MG; Nketiah EO; Liu J; Schmalhofer W; Thomas A; Williams B; Beers L; Smith L; Hafey M; Bleasby K; Leone J; Tang YS; Braun M; Ujjainwalla F; McCann ME; Kaczorowski GJ; Garcia ML
    Mol Pharmacol; 2008 Apr; 73(4):1072-84. PubMed ID: 18187582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and evaluation of 1H-pyrrole-2,5-dione derivatives as cholesterol absorption inhibitors for suppressing the formation of foam cells and inflammatory response.
    Yuan X; Xia Y; Lu P; Zhu L; Zhong Y; Wang Y
    Bioorg Med Chem; 2018 May; 26(8):1435-1447. PubMed ID: 29496412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virtual screening for cholesterol absorption inhibitors.
    Sun L; Qian H; Huang W
    Med Chem; 2014; 11(1):2-12. PubMed ID: 24773346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenylalanine-Derived β-Lactam TRPM8 Modulators. Configuration Effect on the Antagonist Activity.
    Bonache MÁ; Llabrés PJ; Martín-Escura C; De la Torre-Martínez R; Medina-Peris A; Butrón L; Gómez-Monterrey I; Roa AM; Fernández-Ballester G; Ferrer-Montiel A; Fernández-Carvajal A; González-Muñiz R
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33673444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Total synthesis of ezetimibe, a cholesterol absorption inhibitor.
    Śnieżek M; Stecko S; Panfil I; Furman B; Chmielewski M
    J Org Chem; 2013 Jul; 78(14):7048-57. PubMed ID: 23763523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aminopeptidase N (CD13) is a molecular target of the cholesterol absorption inhibitor ezetimibe in the enterocyte brush border membrane.
    Kramer W; Girbig F; Corsiero D; Pfenninger A; Frick W; Jähne G; Rhein M; Wendler W; Lottspeich F; Hochleitner EO; Orsó E; Schmitz G
    J Biol Chem; 2005 Jan; 280(2):1306-20. PubMed ID: 15494415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, biological evaluation and cocrystal structures with tubulin of chiral β-lactam bridged combretastatin A-4 analogues as potent antitumor agents.
    Zhou P; Liang Y; Zhang H; Jiang H; Feng K; Xu P; Wang J; Wang X; Ding K; Luo C; Liu M; Wang Y
    Eur J Med Chem; 2018 Jan; 144():817-842. PubMed ID: 29306206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-Activity Relationship Studies of β-Lactam-azide Analogues as Orally Active Antitumor Agents Targeting the Tubulin Colchicine Site.
    Fu DJ; Fu L; Liu YC; Wang JW; Wang YQ; Han BK; Li XR; Zhang C; Li F; Song J; Zhao B; Mao RW; Zhao RH; Zhang SY; Zhang L; Zhang YB; Liu HM
    Sci Rep; 2017 Oct; 7(1):12788. PubMed ID: 28986548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The synergistic hypocholesterolemic activity of the potent cholesterol absorption inhibitor, ezetimibe, in combination with 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors in dogs.
    Davis HR; Pula KK; Alton KB; Burrier RE; Watkins RW
    Metabolism; 2001 Oct; 50(10):1234-41. PubMed ID: 11586500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sugar-substituted 2-azetidinone cholesterol absorption inhibitors: enhanced potency by modification of the sugar.
    Vaccaro WD; Davis HR
    Bioorg Med Chem Lett; 1998 Feb; 8(3):313-8. PubMed ID: 9871676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diastereoselective synthesis of potent antimalarial cis-β-lactam agents through a [2 + 2] cycloaddition of chiral imines with a chiral ketene.
    Jarrahpour A; Ebrahimi E; Sinou V; Latour C; Brunel JM
    Eur J Med Chem; 2014 Nov; 87():364-71. PubMed ID: 25282260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ezetimibe potently inhibits cholesterol absorption but does not affect acute hepatic or intestinal cholesterol synthesis in rats.
    van Heek M; Farley C; Compton DS; Hoos LM; Smith-Torhan A; Davis HR
    Br J Pharmacol; 2003 Apr; 138(8):1459-64. PubMed ID: 12721101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.